Iambic Therapeutics, Inc.

US$10.17As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IAMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$482.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
7.45%
(35.13%)
Hold 11|9|8|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.11
0.12
0.13
0.14
2.90%
1.43%
16.32%
27.59%
Revenue$M
29.36
28.94
30.01
31.56
2.77%
1.84%
5.81%
6.28%
Peers (US$482.1M)
Cap (US$)
PE
483.0M
—
478.7M
30.07x
Capital
TTM
5Y
10Y
Leveragex
1.521
(0.151)
(0.084)
EBIT/Intx
1.252
0.205
0.210
Own earn%
95.57
283.89
222.05
Sh yield%
23.89
39.42
39.59
Owners
Insiders/Inst%
12.34
25.31
Short interest%
3.42
SBC / revenue%
4.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
19–27
$1 testx
0.0
Incr. ROIC%
0